[go: up one dir, main page]

WO2013067358A3 - Détection de l'arthrose - Google Patents

Détection de l'arthrose Download PDF

Info

Publication number
WO2013067358A3
WO2013067358A3 PCT/US2012/063334 US2012063334W WO2013067358A3 WO 2013067358 A3 WO2013067358 A3 WO 2013067358A3 US 2012063334 W US2012063334 W US 2012063334W WO 2013067358 A3 WO2013067358 A3 WO 2013067358A3
Authority
WO
WIPO (PCT)
Prior art keywords
osteoarthritis
detection
methods
biomarkers
progression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/063334
Other languages
English (en)
Other versions
WO2013067358A2 (fr
Inventor
John A. Todd
Mukundan Attur
Jeffrey David GREENBERG
Steven Abramson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Singulex Inc
Original Assignee
New York University NYU
Singulex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU, Singulex Inc filed Critical New York University NYU
Publication of WO2013067358A2 publication Critical patent/WO2013067358A2/fr
Anticipated expiration legal-status Critical
Publication of WO2013067358A3 publication Critical patent/WO2013067358A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés pour déterminer la gravité, le risque, l'évolution de l'arthrose et des méthodes de traitement utilisant des biomarqueurs dans des échantillons biologiques provenant d'un patient.
PCT/US2012/063334 2011-11-04 2012-11-02 Détection de l'arthrose Ceased WO2013067358A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161556158P 2011-11-04 2011-11-04
US61/556,158 2011-11-04

Publications (2)

Publication Number Publication Date
WO2013067358A2 WO2013067358A2 (fr) 2013-05-10
WO2013067358A3 true WO2013067358A3 (fr) 2015-06-25

Family

ID=48193036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/063334 Ceased WO2013067358A2 (fr) 2011-11-04 2012-11-02 Détection de l'arthrose

Country Status (1)

Country Link
WO (1) WO2013067358A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110218116A1 (en) * 2010-03-05 2011-09-08 The Curators Of The University Of Missouri Biomarkers of osteoarthritis
US20120065094A1 (en) * 2010-09-14 2012-03-15 New York University Methods and kits for diagnosing osteoarthritis and predicting progression

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110218116A1 (en) * 2010-03-05 2011-09-08 The Curators Of The University Of Missouri Biomarkers of osteoarthritis
US20120065094A1 (en) * 2010-09-14 2012-03-15 New York University Methods and kits for diagnosing osteoarthritis and predicting progression

Also Published As

Publication number Publication date
WO2013067358A2 (fr) 2013-05-10

Similar Documents

Publication Publication Date Title
WO2012054588A3 (fr) Dispositifs à conduits et procédés de détection et de traitement d'analytes
WO2012054639A3 (fr) Systèmes de rmn et procédés de détection rapide d'analytes
AU2012273121A1 (en) Devices, solutions and methods for sample collection
WO2013022786A3 (fr) Biomarqueurs micro-arn
EP2705130A4 (fr) Appareil et procédé pour la préparation, la réaction et la détection intégrées d'échantillons
EP2454587A4 (fr) Dispositifs, procédés et coffrets pour déterminer des concentrations d'analyte
EP2663402A1 (fr) Systèmes, procédés et appareils d'imagerie d'un échantillon à des fins d'analyse biologique ou chimique
EP2594944A4 (fr) Dispositif d'analyse automatique, procédé d'analyse et dispositif de traitement d'information
WO2013066369A3 (fr) Procédés de détection de maladie du greffon contre l'hôte
EP2656059A4 (fr) Procédé et dispositif de détection d'ions d'analytes
EP4495267A3 (fr) Kit ou dispositif de détection du cancer du sein, et procédé de détection
EP2375244A4 (fr) Analyseur du système de coagulation sanguine, de même que procédé et programme d'analyse de système de coagulation sanguine
LT3831283T (lt) Analitės jutiklio įrenginiai, sujungimai ir būdai
EP2515121A4 (fr) Dispositif de traitement d'échantillon, procédé de traitement d'échantillon, et contenant de réaction utilisé dans ces dispositifs et procédé associé
EP2508891A4 (fr) Analyseur de coagulation sanguine
EP2672270A4 (fr) Système d'analyse d'échantillon, dispositif d'analyse d'échantillon et procédé d'analyse d'échantillon
EP4365602A3 (fr) Biomarqueur du cancer de l'estomac et procédé de détection
EP2581746A4 (fr) Dispositif et procédé d'analyse d'échantillons
EP2669662A4 (fr) Procédé d'analyse et dispositif de lecture pour micropuce
EP3216852A4 (fr) Procédé d'introduction d'acide nucléique, procédé de détection d'acide nucléique, procédé d'analyse de constituant biologique, dispositif de réseau pour le dosage de constituant biologique, et kit pour l'analyse de constituant biologique
EP2485059A4 (fr) Système d'automatisation du traitement d'analyte
EP3256849A4 (fr) Dispositifs, solutions et procédés destinés à des applications, une analyse et un diagnostic associés à un prélèvement d'échantillons
ZA201402460B (en) Assembly for determining the presence or absence of an analyte in a blood sample and analysis unit comprising such an assembly
EP3216879A4 (fr) Sonde à anp, kit et procédé pour la détection du génotype de papillomavirus humain
EP2909589A4 (fr) Appareil et procédés d'analyse ultrasonore d'échantillon biologique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12845998

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12845998

Country of ref document: EP

Kind code of ref document: A2